Recipharm
Collaboration formed to develop and manufacture KAND567
Contract development and manufacturing organisation (CDMO) — Recipharm and Kancera, a development company focused on cancer therapy, have entered into a contract for the development and manufacture of the pharmaceutical candidate KAND567. more
15 Sep 2017 12:04 News
Integrated first in human service launched
Recipharm and Clinical Trial Consultants (CTC) have partnered to launch a new service that will help companies progress projects from early phase formulation development to clinical trial implementation with patients. more
13 Sep 2017 15:22 Technology
Manufacturing line set up for novel prostate cancer product
Recipharm, the contract development and manufacturing organisation (CDMO), and LIDDS have collaborated to set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, at Recipharm’s development facility in Solna, Sweden. more
21 Jul 2017 11:24 News
The serialisation landscape: Challenges and opportunities for a CDMO
Erik Haeffler, vice president of manufacturing services, Recipharm, examines the challenges and opportunities for a CDMO in the landscape of serialisation that contract partners must overcome. more
6 Jun 2017 14:50 Opinion
Strategic appointment announced by Recipharm
Contract development and manufacturing organisation (CDMO), Recipharm, has announced the strategic appointment in the UK and Ireland of Shabbir Mostafa. Mostafa will join the business management team as director. more
30 May 2017 12:04 News
First batch of serialised drugs delivered to Saudi Arabia
Contract development and manufacturing organisation (CDMO), Recipharm, has delivered its first batch of serialised drug products to Saudi Arabia. This follows the introduction of new regulatory requirements in March this year. more
24 Apr 2017 12:11 News
Recipharm appoints new chief financial officer
Henrik Stenqvist has been appointed as the new executive vice president and chief financial officer of Recipharm. more
11 Apr 2017 11:15 News
Recipharm and Sato partner to manufacture product for Japan
Recipharm, the contract development and manufacturing organization (CDMO), has entered into a long-term agreement with Sato Pharmaceuticals for the commercial manufacture and delivery of Emla Patch to Japanese market. more
27 Mar 2017 11:05 News
Recipharm completes strategic acquisition in India
Contract development and manufacturing organisation, Recipharm, has announced that it has completed the acquisition of biopharma organisation Kemwell’s pharmaceutical business, located in Bengaluru India. more
27 Feb 2017 16:30 News
What's in store for pharma in 2017?
We spoke with four of the leading lights in the sector to find out what they think 2017 has in store for pharma more
17 Feb 2017 14:30 News
Recipharm increases lyophilisation capacity in Italy
Recipharm has announced a €3.7 million investment to expand its lyophilisation capacity in Italy in response to growing customer demand more
25 Aug 2016 12:26
CDMO invests €40m in better serialisation
CDMO Recipharm has partnered with firms Marchesini, SEA Vision and TraceLink to develop new serialisation services. more
22 Jun 2016 09:49 Technology
How solid dose formulations can optimise time-to-market
Sophisticated solid dose formulations for fixed dose combinations – Jean-François Hilaire, Recipharm, explains how CDMOs can help optimise time-to-market more
9 May 2016 09:10 Opinion
Recipharm closes deal on Indian injectables business
Recipharm acquires a majority stake in Nitin Lifesciences (Nitin), an Indian sterile injectables CMO more
13 Apr 2016 13:54 News
Recipharm acquires Mitim for £53.5m
Recipharm has acquired Mitim for £53.5m, adding scale and technology in injectable beta lactams to Recipharm’s portfolio, according to the company more
29 Feb 2016 16:54 News
Kr28 million for Pharmanest's IUD pain relief candidate
Recipharm Venture Fund, Östersjöstiftelsen and Praktikerinvest have jointly invested kr28 million in Pharmanest. Recipharm’s part of the investment is kr8 million. more
9 Jul 2015 11:14 News
OnTarget Chemistry acquisition broadens Recipharm's preclinical offering
Recipharm has bought OnTarget Chemistry, a CRO in Uppsala, Sweden, that specialises in medicinal chemistry, offering synthesis and analytical services that include rare and demanding specialties. more
15 Jun 2015 14:09 News
Recipharm partners with Follicum on drug development
Recipharm hassigned a partnership agreement with Follicum in preparation for a clinical trial of the drug candidate FOL-005. more
2 Jun 2015 08:44 News
Recipharm hires chief strategy officer
CDMO Recipharm has appointed Jean-François Hilaire to the new position of chief strategy officer, joining Recipharm’s group management team. more
1 Jun 2015 11:22 News
Recipharm appoints new General Manager
The contract development and manufacturing organisation, Recipharm, has announced that Giorgio Bruno has been appointed General Manager of Recipharm Italia S.p.A. more
14 May 2015 15:20 News